Detalles de la búsqueda
1.
Effectiveness and safety of primary prophylaxis with G-CSF for lung cancer: a systematic review and meta-analysis to develop clinical practice guidelines for the use of G-CSF 2022.
Int J Clin Oncol
; 29(4): 355-362, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38353907
2.
Effectiveness and safety of primary prophylaxis of G-CSF during chemotherapy for prostate cancer, Japanese clinical guideline for appropriate use of G-CSF: clinical practice guidelines for the use of G-CSF 2022.
Int J Clin Oncol
; 29(5): 559-563, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38538963
3.
Optimal timing of prophylactic pegylated G-CSF after chemotherapy administration for patients with cancer: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022.
Int J Clin Oncol
; 29(5): 551-558, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38526621
4.
Effectiveness and safety of primary prophylaxis with G-CSF after induction therapy for acute myeloid leukemia: a systematic review and meta-analysis of the clinical practice guidelines for the use of G-CSF 2022 from the Japan society of clinical oncology.
Int J Clin Oncol
; 29(5): 535-544, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38494578
5.
Effectiveness and safety of primary prophylaxis of granulocyte colony-stimulating factor during dose-dense chemotherapy for urothelial cancer: Clinical Practice Guidelines for the Use of G-CSF 2022.
Int J Clin Oncol
; 29(5): 545-550, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38517658
6.
Effectiveness of G-CSF in chemotherapy for digestive system tumors: a systematic review of the Clinical Practice Guidelines for the Use of G-CSF 2022 delineated by the Japan Society of Clinical Oncology.
Int J Clin Oncol
; 29(6): 689-699, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38578596
7.
Comparison between a single dose of PEG G-CSF and multiple doses of non-PEG G-CSF: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022.
Int J Clin Oncol
; 29(6): 681-688, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38649648
8.
Therapeutic use of granulocyte colony-stimulating factor (G-CSF) in patients with febrile neutropenia: a comprehensive systematic review for clinical practice guidelines for the use of G-CSF 2022 from the Japan Society of Clinical Oncology.
Int J Clin Oncol
; 29(6): 700-705, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38696053
9.
Effectiveness and safety of granulocyte colony-stimulating factor priming regimen for acute myeloid leukemia: A systematic review and meta-analysis of the Clinical Practice Guideline for the use of G-CSF 2022 from the Japan Society of Clinical Oncology.
Int J Clin Oncol
; 29(7): 899-910, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38755516
10.
Primary prophylaxis with G-CSF for patients with non-round cell soft tissue sarcomas: a systematic review for the Clinical Practice Guidelines for the Use of G-CSF 2022 of the Japan Society of Clinical Oncology.
Int J Clin Oncol
; 2024 Jun 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38865026
11.
Effectiveness and safety of primary prophylaxis with G-CSF during chemotherapy for invasive breast cancer: a systematic review and meta-analysis from Clinical Practice Guidelines for the Use of G-CSF 2022.
Int J Clin Oncol
; 2024 Jun 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38900215
12.
Effectiveness and safety of primary prophylaxis with G-CSF for patients with Ewing sarcomas: a systematic review for the Clinical Practice Guidelines for the Use of G-CSF 2022 of the Japan Society of Clinical Oncology.
Int J Clin Oncol
; 2024 Jun 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38904887
13.
High concentration of oxaliplatin may be a risk factor for vascular pain.
J Clin Pharm Ther
; 47(4): 462-468, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-34743376
14.
Randomized, Double-Blind, Placebo-Controlled Phase â ¡ Study on the Efficacy and Safety of Vitamin K1 Ointment for Cetuximab or Panitumumab-Induced Acneiform Eruptions-VIKTORIA Study.
Gan To Kagaku Ryoho
; 47(6): 933-939, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32541171
15.
Pharmacist-led intervention in the multidisciplinary team approach optimizes heart failure medication.
Heart Vessels
; 33(6): 615-622, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29204682
16.
Incidence of Ophthalmic Disorders in Patients Treated with the Antineoplastic Agent S-1.
Gan To Kagaku Ryoho
; 44(6): 501-506, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28698442
17.
Development of Support System for Breast Cancer Patients--Managing Side Effects through an Internet-Based System.
Gan To Kagaku Ryoho
; 43(1): 85-90, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26809531
18.
Assessment of Injection Site Reactions for Peripheral Intravenous Oxaliplatin Infusion and Potential Remedies.
Gan To Kagaku Ryoho
; 43(8): 985-8, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27539041
19.
[Emetogenic potential of antineoplastic agents based on clinical trials in Japan].
Gan To Kagaku Ryoho
; 42(3): 335-41, 2015 Mar.
Artículo
en Japonés
| MEDLINE | ID: mdl-25812503
20.
Concomitant polypharmacy is associated with irinotecan-related adverse drug reactions in patients with cancer.
Int J Clin Oncol
; 18(4): 735-42, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22638624